Log In
Print
BCIQ
Print
Print this Print this
 

Mabtas, Biosimilar rituximab

  Manage Alerts
Collapse Summary General Information
Company Intas Pharmaceuticals Ltd.
DescriptionBiosimilar of rituximab
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today